Department of Transportation proposes amendments to drug testing program
The Department of Transportation (DOT) published a notice in the Federal Register proposing to amend its drug testing program to add four opioids to its drug testing panel. Read More
Reminder: DOT expanding drug testing to include opioids on Jan. 1, 2018
The U.S. Department of Transportation (DOT) recently posted an additional notice in anticipation of the upcoming Jan. 1, 2018 effective date. Read More
D.C. court tosses truck drivers’ FCRA suit over inaccurate DOT database
Commercial truck drivers who sued the Department of Transportation (DOT) over inaccurate safety records in a DOT database lacked standing to pursue their Fair Credit Reporting Act (FCRA) claims, the D.C. Circuit ruled. Read More
DOT publishes guidance for updating drug and alcohol policies in light of recent opioid testing update
On Jan. 1, 2018, the U.S. Department of Transportation (DOT) will expand its current panel to require testing for semi-synthetic opioids. The semi-synthetic drugs that must be tested for are: hydrocodone, hydromorphone, oxymorphone, and oxycodone. Read More
Guidance Issued for DOT-Regulated Employers Regarding Drug and Alcohol Testing Requirements
In light of the COVID-19 pandemic, the DOT and the FMCSA have issued guidance on compliance with DOT drug and alcohol testing programs, in effect until June 30, 2020. Read More